Uttar Pradesh

Pharma Courses  
  • PharmaTutor
    28 October 2012

    A REVIEW ON: AEGLE MARMELOS

    About Authors:
    Kishan Singh *, Krishn Kumar Agrawal
    Institute of Pharmaceutical Research GLA University,
    Mathura-281403 (U.P.) India.
    *kishan.singh575@gmail.com

    ABSTRACT
    Herbal drugs are traditionally used in various parts of the world to cure different diseases. The Ayurvedic and Siddha medical systems are very famous medical practices in Indian traditional medicines. Over the last few ,researcher have aimed at identifying and validation plant derived substance for the treatment of various disease .similarly it has been already proved that various parts of plants such as leaf, fruits seeds etc.provide heath and nutrition promoting compounds traditional used against various disease. Aegle marmelos have been used in ethno medicine to exploit its’ medicinal properties including astringent, antidiarrheal antidysentric, demulcent, antipyretic, and anti-inflammatory activities. The present review aims to complete medicinal values of Aegle marmelos generated through the research activity using modern scientific approaches and innovative scientific tools.

  • 24 October 2012
    Indian Institute of Technology Kanpur invites Ph.D. programmes for the session commencing from December 2012.

  • 21 October 2012
    Kanpur institute of technology (KIT) invites Director/ Professors/ Associate Professors/ Assistant Professors/ Lecturers (Selection Grade)/ Senior Lecturers/ Lecturers

    Kanpur institute of technology (KIT) has been founded by ITES. The society was founded by Mr.P.K. jain, Mrs. Neena Verma, Mr.Anil Kumar Agrawal and Mr.Vipul jain with the aim of  providing state of art education in the field of  engineering and technology . the found member of the society are highly motivated visionaries and  are the venture.

  • 18 October 2012
    Applications are invited for the post of Junior Research Fellow/ Senior Research Fellow/ Research Associate in Banaras Hindu University

    Banaras Hindu University ranks among the first few in the country in the field of academic and research output.

  • 16 October 2012
    NOVEL FAST DISSOLVING TABLETS: A COMPREHENSIVE REVIEW

    About Authors:
    Tyagi Nitin*, Singh Vikram Jeet, Mishra Santosh Kumar
    CARPS, Faculty of Pharmaceutical Sciences, Shobhit University,
    Meerut, U.P.(250110), India.
    *nitintyagi27@yahoo.in

    Abstract
    These tablets were introduced in 1980s in the market  and since their introduction in the market the fast dissolving tablets are gaining popularity regularly. Due to their rapid disintegration or dissolution in the oral cavity as they come into contact of saliva normally with in one minute, without the use of water these provides patient compliance particularly to the pediatric, geriatric ,bedridden patients and for patients who are very much busy in travelling and does not have easy access to water. The present article aims on the recent advancements in the fast dissolving tablets and provides a good information about the advantages,limitations, mechanism of action of superdisintegrants, the conventional and patented development techniques and about the evaluation parameters of the fast dissolving tablets.

  • 15 October 2012
    Opportunity for M.Pharm, M.Sc, B.Pharm to work in areas of Pharmacognosy/Pharmacology and Tissue culture & Transformation @ CSIR-NBRI

    NBRI is a premier plant based multidisciplinary, state-of-art national R&D Centre of CSIR undertaking research from classical taxonomy to cutting edge areas of modern biology-including both applied and basic research in the fields of biochemistry, bioinformatics, biotechnology, conservation biology, cytogenetics, environmental sciences, ethnopharmacology, floriculture, microbiology, molecular biology and genetic engineering, pharmacognosy

  • 14 October 2012
    Work as Full Time and Part Time - Clinical Trial Operations, CDM, Pharmacovigilance, Medical Writing in Clini India

    Clini India is a progressive and premier academy in clinical research that has rapidly gaining a good reputation for excellence through its innovative approach in clinical research. Clini India is an academy with a good reputation in clinical research industry. Clini India is a premier institution of CR education in clinical research domain. Clini India delivers Full time, Part time and e- learning training in Clinical research education.

  • 10 October 2012
    CDRI invites online applications from M.Pharm/M.Sc for engagement of Project Staff under different projects - 7 Posts

    CSIR-Central Drug Research Institute, Lucknow is a premier R&D Institute under the aegis of the Council of Scientific and Industrial Research (CSIR), New Delhi which is an autonomous body under Department of Scientific and Industrial Research, Government of India.

  • 2 October 2012
    TAK-875- A NEWER NOVEL ORAL TREATMENT FOR TYPE-2 DIABETES: A REVIEW

    About Authors:
    Satyanand tyagi*, Raghvendra1
    *President, Tyagi Pharmacy Association & Scientific Writer,
    Chattarpur, New Delhi, India-110074.
    Prof. Satyanand Tyagi is a life time member of various pharmacy professional bodies like IPA, APTI and IPGA. He has published various research papers and review articles. His academic works include 45 Publications (37 Review Articles and 08 Research Articles of Pharmaceutical, Medicinal and Clinical Importance, published in standard and reputed National and International Pharmacy journals; Out of 45 publications, 10 are International Publications).
    1Department of Pharmaceutics, Aligarh College of Pharmacy,
    Aligarh, U.P, India-202001.
    *sntyagi9@yahoo.com,     +91-9871111375 / 9582025220

    ABSTRACT
    Tak-875, a new treatment for type-2 diabetes, improves blood sugar control and is equally effective as glimepiride (Sulfonylurea, oral hypoglycaemic agent), but has a significantly lower risk of hypoglycaemia, according to a new study. It works by boosting the release of insulin from pancreatic beta cells when glucose and fatty acids rise in the blood, such as after a meal, which results in a fall in blood glucose levels. TAK-875 is a novel oral medication designed to enhance insulin secretion in a glucose dependent manner, which means that it has no effect on insulin secretion when glucose levels are normal, and as such has the potential to improve the control of blood sugar levels without the risk of hypoglycaemia. The pill belongs to a new class of treatments called GPR40 agonists, which activate a receptor that stimulates and regulates insulin production. New treatments are needed because of “the expected increase in the number of cases of Type 2 diabetes during the next few decades” and because some current drugs have “insufficient effect,” the researchers, led by Charles Burant at the University of Michigan Medical School, wrote in the study. Free fatty acid receptor 1 (FFA1), also known as G protein-coupled receptor 40 (GPR40), plays a vital role in stimulating and regulating the production of insulin. It works by boosting the release of insulin from pancreatic β-cells when glucose and fatty acids rise in the blood, such as after a meal. The release of insulin results in a fall in blood glucose levels. Drugs that activate the FFAR1 receptor have the potential to help diabetics release more insulin and improve control of blood glucose levels. This article gives an overview about this newly introduced drug TAK-875 and its role in treatment for type-2 diabetes.

    [adsense:336x280:8701650588]

  • 2 October 2012
    Rajendra Memorial Research Institute of Medical Sciences invites Clinical Research Assistant - Walk in interview

    Rajendra Memorial Research Institute of Medical Sciences, Patna, a permanent Institute under Indian Council of Medical Research, Dept. Of Health Research, Ministry of Health & Family Welfare, Govt.

Subscribe to Uttar Pradesh